“I don’t see any motive, but I think they’re not independent of each other,” Rambaut says. “Once we get that idea, people will look at the saved samples to see what they can find.”
Other studies that have reported that the virus was detected earlier in Italy have similar errors. An examination Published in August 2020, by the Department of the Environment and Health of Rome, the Sars-CoV-2 RNA taken on 18 December 2019 was detected on 18 December 2019 in the cities of Milan and Turin. These findings sparked suspicions of Alex Crits-Christoph, a postdoctoral fellow at Johns Hopkins University, specializing in bioinformatics analysis of genetic data. The researchers performed three different tests, but only one was positive. They also invented their own primers, which are used to target specific regions of RNA, despite the fact that there were standardized primers for Sars-CoV-2 around the world at the time. “I find that weird,” he says.
On October 28, 2020, a examination was sent to the magazine Tumors and they admitted the next day, “at least it’s a very quick expert assessment that reveals, maybe not even a review,” Worobey says. The researchers looked at antibodies from volunteers registered in an attempt to study lung cancer from all regions of Italy, and more than a hundred of the participants developed antibodies against coronavirus in September 2019. “Our results indicate that the outbreak of the Covid-19 pandemic also spread to Lombardy, which circulated in Italy before the official cases of Sars-CoV -2 Covid-19, which were circulated in Lombardy long before the first official reports from the Chinese authorities,” the authors wrote. They theorized in interviews they could detect a “less polluting” voltage that could circulate without triggering a major occurrence. It was a wide paper covered according to He speaks English media. But others have pointed out major flaws in the paper. The researchers did not take the necessary measures to detect other antibodies to the coronavirus, such as the common cold. “Any antibody test has false positives, so when you look at a group of people who are in a very low prevalence situation, most of the positives will be false,” says Marion Koopmans, a virologist at the Erasmus Medical Center. The WHO team traveled to Wuhan to investigate the onset of the coronavirus pandemic. It was research stated in the investigation Magazines in March 2021, but no corrections were ever made. The WHO requested that the samples be retested in other laboratories. The research he has found that none of the samples he had a high enough level of antibody to be evidence of infection.
Another one examination On November 10, he examined the skin biopsy of a 25-year-old woman living in Milan when she suffered a rash at the hospital. A few months later, Raffaele Gianotti, the lead researcher and dermatologist who treated him, found evidence of Sars-CoV-2 molecules in a skin sample. The WHO wanted to investigate the case, but now no one can locate a sick woman, and Gianotti died in March. (The rest of the authors in the paper say there is nothing new about the case.)
Rambaut says these findings “are used by various parties to support a particular set of narratives.” In particular, they have been covered often according to Chinese state media outlets were circulating investigations to suggest that China was not the country of origin of the virus. “Wuhan was the first time the coronavirus was detected, but it was not the origin,” he said Zeng Guang, former chief epidemiologist at the China Center for Disease Control and Prevention, at an academic conference in November 2020.